LOTREL Safety Questions, LOTREL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LOTREL. Our extensive database of LOTREL adverse events and LOTREL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LOTREL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



LOTREL Safety Reports

Total LOTREL reports: 237.
LOTREL FDA safety alerts: No.
Reported deaths: 6    Reported hospitalizations: 94.
Take LOTREL Side Effects Survey or Share Your LOTREL Story. LOTREL Usage.

Showing 1-75 of 237 Next >

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Oct 11, 2006. Male patient was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled. LOTREL dosage: unknown. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2006. Female patient, 63 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: pruritus, rash. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Dec 06, 2006. Female patient, 64 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: cough, influenza like illness, liver function test abnormal. LOTREL dosage: 5/20 MG, ORAL. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on Oct 17, 2006. Male patient, 29 years of age, weighting 224.0 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled. LOTREL dosage: unknown. During the same period patient was treated with VITAMIN, ASPIRIN, VIAGRA, GINKOBIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Dec 18, 2006. Male patient, 53 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled. LOTREL dosage: 5/20 MG, QD, ORAL. Patient recovered.

LOTREL problem was reported by a Health Professional from UNITED STATES on Oct 26, 2006. Male patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema. LOTREL dosage: 5/40 MG OR 10/40 MG QD, ORAL. During the same period patient was treated with TARKA. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Jan 09, 2007. Female patient, 62 years of age, weighting 140.0 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema, bronchitis, cough, erythema, local swelling, lymphadenopathy, pharyngeal oedema, rhinitis allergic, speech disorder. LOTREL dosage: 5/20 MG, QD, ORAL. During the same period patient was treated with CITRACAL, VITAMINS. Patient recovered.

LOTREL problem was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Male patient, 26 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, heart rate increased. LOTREL dosage: 5/10 MG, QD, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Nov 08, 2006. Female patient, 49 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, headache. LOTREL dosage: unknown. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Female patient was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, hypotension. LOTREL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Sept 26, 2006. Male patient was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, stent placement. LOTREL dosage: unknown. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on Sept 13, 2006. Female patient, 52 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema, swelling face, urticaria. LOTREL dosage: 10/20 MG, QD, ORAL. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Sept 14, 2006. Male patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema, swelling face. LOTREL dosage: unknown. During the same period patient was treated with TOPROL, DIOVAN HCT. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2006. Male patient, 63 years of age, was diagnosed with hypertension, diabetes mellitus non-insulin-dependent and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: dizziness, haemoglobin decreased, liver function test abnormal. LOTREL dosage: 20 MG, QD, ORAL. During the same period patient was treated with AVANDAMET, GEMFIBROZIL. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Oct 06, 2006. Male patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase mb increased, chest pain, electrocardiogram abnormal, myocardial infarction, troponin i increased, ventricular hypokinesia. LOTREL dosage: unknown. During the same period patient was treated with ALLOPURINOL, INDOCIN. Patient was hospitalized. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2006. Male patient, 78 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: chest pain, hypoaesthesia, oedema peripheral. LOTREL dosage: unknown. During the same period patient was treated with TOPROL, ISOSORBIDE MONONITRATE, LIPITOR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Oct 04, 2006. Female patient, 69 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, hypertension. LOTREL dosage: unknown. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 05, 2006. Female patient was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: swelling face, swollen tongue. LOTREL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Oct 07, 2006. Male patient was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled. LOTREL dosage: unknown. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2006. Female patient, 69 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: auricular swelling, dysphagia, swelling face, swollen tongue. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Aug 14, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: constipation. LOTREL dosage: unknown. During the same period patient was treated with COREG, BACLOFEN. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2006. Female patient, 55 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: hypertension. LOTREL dosage: 5/10 MG, QD, ORAL. During the same period patient was treated with OSCAL. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Nov 02, 2006. Female patient, 75 years of age, weighting 151.0 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema. LOTREL dosage: 5/10 MG, QD, ORAL. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on Nov 07, 2006. Female patient, 74 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: hypotension. LOTREL dosage: 5MG AMLODIPINE/10MG ENAZEPRIL, QD, ORAL. During the same period patient was treated with ATENOLOL, FOSAMAX, NASONEX, COSOPT, PRESER VISION. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Aug 29, 2006. Female patient, 59 years of age, weighting 198.9 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema. LOTREL dosage: 5/20 MG, BID, ORAL. During the same period patient was treated with SINGULAIR, HYDROCHLOROTHIAZIDE, ADVAIR DISKUS, CENESTIN, ALBUTEROL, ACIPHEX. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on Sept 01, 2006. Male patient, 54 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema, oedema peripheral. LOTREL dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, PRILOSEC. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Sept 05, 2006. Female patient, 46 years of age, weighting 244.9 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema. LOTREL dosage: 5/20 MG, QD, ORAL. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on Sept 05, 2006. Male patient, 73 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: hypotension, myocardial infarction. LOTREL dosage: 5/10MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Sept 26, 2006. Female patient, 78 years of age, weighting 144.0 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema, swollen tongue. LOTREL dosage: unknown. During the same period patient was treated with DIOVAN HCT. Patient was hospitalized. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on July 07, 2006. Male patient, 67 years of age, weighting 140.9 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema, dry mouth, dyspnoea, oropharyngeal swelling, paraesthesia oral, swollen tongue, white blood cell count increased. LOTREL dosage: 10/20 MG, QD, ORAL. During the same period patient was treated with SYNTHROID, VIAGRA, EFFEXOR. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on July 19, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. LOTREL dosage: unknown. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on Jan 12, 2007. Male patient, 73 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood bilirubin increased, chest discomfort, cholestasis, chromaturia, gait disturbance, hepatic enzyme increased, hepatocellular damage, immobile. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on July 19, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. LOTREL dosage: unknown. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on July 27, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: pancreatitis. LOTREL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Aug 01, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: pancreatitis. LOTREL dosage: unknown. During the same period patient was treated with LISINOPRIL. Patient was hospitalized. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on Aug 02, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Aug 02, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on Aug 02, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Aug 04, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, incorrect dose administered. LOTREL dosage: unknown. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on May 23, 2006. Male patient, 60 years of age, was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, swollen tongue. LOTREL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on June 05, 2006. Female patient, 51 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: asthenia, blood pressure inadequately controlled, nausea. LOTREL dosage: 5MG AMLODIPINE/20MG BENAZEPRILP, QD, ORAL. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on June 08, 2006. Male patient, 60 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema, lip swelling, local swelling, throat tightness. LOTREL dosage: 10/20 MG, QD, ORAL. During the same period patient was treated with LEXAPRO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on June 12, 2006. Male patient, 51 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, pharyngeal oedema, swelling face, swollen tongue. LOTREL dosage: 10/20 MG, QD, ORAL. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Female patient, 38 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: swelling face, throat tightness. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on June 23, 2006. Female patient, 72 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: local swelling. LOTREL dosage: 10/20 MG, QD, ORAL. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on June 26, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LOTREL problem on July 31, 2006. Male patient, 63 years of age, weighting 177.9 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. LOTREL dosage: 10/20 MG, QD, ORAL. During the same period patient was treated with ZETIA, UROXATRAL, NORVASC, PROSCAR, NEURONTIN, COZAAR, AMARYL. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on July 04, 2006. Male patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, myocardial infarction. LOTREL dosage: 10/20 MG, ORAL. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on Mar 09, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: nausea. LOTREL dosage: unknown. During the same period patient was treated with ATENOLOL. Patient was hospitalized. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on Mar 13, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, swollen tongue. LOTREL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on June 02, 2006. Female patient was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: azotaemia, blood creatinine increased, dizziness, hypotension. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

LOTREL problem was reported by a Health Professional from UNITED STATES on Apr 10, 2006. Female patient, 80 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled. LOTREL dosage: 10/20 MG, QD, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on July 07, 2006. Male patient, 58 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled. LOTREL dosage: unknown. Patient recovered.

LOTREL problem was reported by a Health Professional from UNITED STATES on Apr 14, 2006. Male patient was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: rash, swelling face. LOTREL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Apr 25, 2006. Female patient was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, gingival disorder, myalgia, renal impairment. LOTREL dosage: unknown. During the same period patient was treated with LIPITOR. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2006. Female patient, 38 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, dizziness, paralysis, speech disorder. LOTREL dosage: 10MG AML / 20MG BEN QD. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on May 05, 2006. Female patient, 75 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, dysuria, erythema, heart rate increased, palpitations. LOTREL dosage: 10/20 MG, QD, ORAL. During the same period patient was treated with CLONIDINE, ATENOLOL, PERCOCET, ULTRACET. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on May 10, 2006. Male patient, weighting 200.0 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema, oedema peripheral, swelling face. LOTREL dosage: 5/20 MG, QD, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on May 25, 2007. Female patient, 48 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: dizziness, electrocardiogram abnormal, hot flush, panic attack. LOTREL dosage: unknown. During the same period patient was treated with DIOVAN. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Male patient, 69 years of age, was diagnosed with hypertension, hypersensitivity and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: neuropathy, oedema peripheral, paraesthesia. LOTREL dosage: 5/20 MG, QD. During the same period patient was treated with VITAMIN CAP, ATENOLOL, ASPIRIN, ALLEGRA. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on June 06, 2007. Male patient, weighting 270.0 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: asthenia, blood potassium increased, bradycardia. LOTREL dosage: unknown. During the same period patient was treated with DIOVAN, TEKTURNA, LASIX, COUMADIN, AMIODARONE, DIGOXIN. Patient was hospitalized. Patient recovered.

LOTREL problem was reported by a Physician from UNITED STATES on May 29, 2007. Male patient, 84 years of age, weighting 165.4 lb, was diagnosed with hypertension, benign prostatic hyperplasia, urinary incontinence and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anuria, blood creatinine increased, chest pain, dysphagia, fall, gait disturbance, head injury, hyperglycaemia. LOTREL dosage: unknown. During the same period patient was treated with FLOMAX, DETROL, LIPITOR, CALCIUM CARBONATE W, ALLOPURINOL, DIFLUCAN, LISINOPRIL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on June 07, 2007. Male patient, 69 years of age, weighting 207.0 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: arthritis, back pain, concomitant disease progression, dizziness, hyperhidrosis, nausea, surgery. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2007. Female patient, 51 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: dizziness, eating disorder, headache, hypotension, loss of consciousness, nausea, vomiting. LOTREL dosage: 10/20 MG, QD. During the same period patient was treated with BENICAR. Patient recovered.

Health Professional from UNITED STATES reported LOTREL problem on June 22, 2007. Female patient, weighting 241.0 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: dizziness, paraesthesia. LOTREL dosage: 10/20MG 1 TAB DAILY ORAL. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on June 22, 2007. Male patient, 87 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: heart rate increased, oedema peripheral. LOTREL dosage: 5/? MG DAILY. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on June 21, 2007. Female patient, 68 years of age, weighting 171.3 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, concomitant disease progression, diabetic nephropathy, dyspnoea, dyspnoea exertional, fluid overload, oedema, orthopnoea, proteinuria. LOTREL dosage: unknown. During the same period patient was treated with LABETALOL, LASIX. Patient was hospitalized. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2006. Female patient, 73 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: skin cancer, therapeutic procedure. LOTREL dosage: 5/10 MG, BID. Patient recovered.

Physician from UNITED STATES reported LOTREL problem on July 10, 2006. Female patient, 82 years of age, weighting 131.4 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree, bradycardia, syncope. LOTREL dosage: unknown. During the same period patient was treated with METOPROLOL. Patient was hospitalized. Patient recovered.

LOTREL problem was reported by a Pharmacist from UNITED STATES on July 20, 2006. Female patient was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, dysphagia, dyspnoea, fatigue, gait disturbance, laryngeal oedema, stridor. LOTREL dosage: 10/20 MG DAILY PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Feb 06, 2006. Female patient, 82 years of age, was diagnosed with hypertension, depression and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: anorexia, apathy, asthenia, blood creatinine increased, blood urea increased, hypersomnia, nephritis interstitial. LOTREL dosage: unknown. During the same period patient was treated with ACIPHEX, LEXAPRO, HYDROCHLOROTHIAZIDE W. Patient recovered.

LOTREL problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Female patient, 54 years of age, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, retinal artery occlusion, telangiectasia. LOTREL dosage: 5/20 MG, QD. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Aug 10, 2006. Female patient, 82 years of age, weighting 143.5 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: anaemia, blood cholesterol increased, fluid overload, myocardial ischaemia, renal failure acute, sepsis. LOTREL dosage: unknown. During the same period patient was treated with ATENOLOL, AMBIEN, GLYBURIDE, LOVASTATIN, ARANESP. Patient died.

LOTREL problem was reported by a Health Professional from UNITED STATES on Aug 08, 2006. Female patient, 85 years of age, weighting 136.0 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: cellulitis, pitting oedema. LOTREL dosage: 5/10 MG, BID. During the same period patient was treated with SYNTHROID, PRAVACHOL, TAGAMET, LASIX, PREDNISONE, CLINORIL, PENTASA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LOTREL problem on Aug 11, 2006. Female patient, 70 years of age, was diagnosed with blood pressure abnormal and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, chromatopsia, rectal discharge, vomiting projectile. LOTREL dosage: unknown. Patient was hospitalized. Patient recovered.

Showing 1-75 of 237 Next >

Ask Our Patient Community about LOTREL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

 Q
Quazepam
Quetiapine
QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase (prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab